RxDoctor Payments Data

Paul Bucolo, MD

Family Medicine · New Smyrna Beach, FLNPI 1871633719

Payments from drug & device makers

$1,580in general payments, 2019–2025

Across 86 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$226
  • Abbott$214
  • Exact Sciences$196
  • Vanda Pharmaceuticals Inc.$147
  • AbbVie$127
  • AstraZeneca$105
  • plus $565 from 17 others

What the payments were for

  • Food & beverage$1,580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,580 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$91,051
Medicare patients
290
Services billed
792

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide91$107,124
OzempicSemaglutide64$87,854
EliquisApixaban58$59,299
XareltoRivaroxaban34$42,906
JardianceEmpagliflozin31$39,524
TrulicityDulaglutide37$33,640
TradjentaLinagliptin31$30,430
FarxigaDapagliflozin Propanediol26$29,518
JanuviaSitagliptin Phosphate21$23,802
EntrestoSacubitril/Valsartan36$23,454
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$17,096
MyrbetriqMirabegron13$9,243
SymbicortBudesonide/Formoterol Fumarate22$6,533
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$6,215
LivaloPitavastatin Calcium14$5,587

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$23$140,764128 claims
Novo NordiskOzempic$226$87,85464 claims
PfizerEliquis$43$59,29958 claims
Johnson & JohnsonXarelto$17$42,90634 claims
AstraZenecaFarxiga, Symbicort$105$36,05148 claims
NovartisEntresto$18$23,45436 claims
GSKTrelegy Ellipta, Anoro Ellipta$16$23,31137 claims
AbbVieSynthroid$127$1,39625 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in New Smyrna Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →